Cargando…
Cysteine-Rich Protective Antigen (CyRPA) as promising blood-stage candidate protein for inclusion in a malaria subunit vaccine
Autores principales: | Favuzza, Paola, Dreyer, Anita M, Wittlin, Sergio, Matile, Hugues, Pluschke, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472695/ http://dx.doi.org/10.1186/1475-2875-11-S1-P30 |
Ejemplares similares
-
Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA
por: Favuzza, Paola, et al.
Publicado: (2016) -
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody
por: Favuzza, Paola, et al.
Publicado: (2017) -
Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models
por: Tamborrini, Marco, et al.
Publicado: (2020) -
Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA)
por: Somanathan, Anjali, et al.
Publicado: (2022) -
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
por: Ragotte, Robert J., et al.
Publicado: (2020)